Unknown

Dataset Information

0

Sensitive mass spectrometric determination of kinin-kallikrein system peptides in light of COVID-19.


ABSTRACT: The outbreak of COVID-19 has raised interest in the kinin-kallikrein system. Viral blockade of the angiotensin-converting enzyme 2 impedes degradation of the active kinin des-Arg(9)-bradykinin, which thus increasingly activates bradykinin receptors known to promote inflammation, cough, and edema-symptoms that are commonly observed in COVID-19. However, lean and reliable investigation of the postulated alterations is currently hindered by non-specific peptide adsorption, lacking sensitivity, and cross-reactivity of applicable assays. Here, an LC-MS/MS method was established to determine the following kinins in respiratory lavage fluids: kallidin, bradykinin, des-Arg(10)-kallidin, des-Arg(9)-bradykinin, bradykinin 1-7, bradykinin 2-9 and bradykinin 1-5. This method was fully validated according to regulatory bioanalytical guidelines of the European Medicine Agency and the US Food and Drug Administration and has a broad calibration curve range (up to a factor of 103), encompassing low quantification limits of 4.4-22.8 pg/mL (depending on the individual kinin). The application of the developed LC-MS/MS method to nasal lavage fluid allowed for the rapid (~?2 h), comprehensive and low-volume (100 µL) determination of kinins. Hence, this novel assay may support current efforts to investigate the pathophysiology of COVID-19, but can also be extended to other diseases.

SUBMITTER: Gangnus T 

PROVIDER: S-EPMC7862273 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sensitive mass spectrometric determination of kinin-kallikrein system peptides in light of COVID-19.

Gangnus Tanja T   Burckhardt Bjoern B BB  

Scientific reports 20210204 1


The outbreak of COVID-19 has raised interest in the kinin-kallikrein system. Viral blockade of the angiotensin-converting enzyme 2 impedes degradation of the active kinin des-Arg(9)-bradykinin, which thus increasingly activates bradykinin receptors known to promote inflammation, cough, and edema-symptoms that are commonly observed in COVID-19. However, lean and reliable investigation of the postulated alterations is currently hindered by non-specific peptide adsorption, lacking sensitivity, and  ...[more]

Similar Datasets

| S-EPMC9258198 | biostudies-literature
| S-EPMC3835742 | biostudies-literature
| S-EPMC7757006 | biostudies-literature
| S-EPMC9352453 | biostudies-literature
| S-EPMC7920028 | biostudies-literature
| S-EPMC3463770 | biostudies-literature
| S-EPMC7937878 | biostudies-literature
| S-EPMC7456998 | biostudies-literature
| S-EPMC6796560 | biostudies-literature
| S-EPMC4587649 | biostudies-literature